CHPJ Articles
Showing 157–166 of 166 resultsSorted by latest
-
Comparing access to new medicines by therapeutic class in public and private sector plans in Canada.
$0.00 Add to cart -
Comparing access to new drugs in Canada’s public and private sector drug plans. 2013 Annual Report.
$0.00 Add to cart -
Medical devices and healthcare costs in Canada and 65 other countries 2006-2011.
$0.00 Add to cart -
Les coûts potentiels découlant de la substitution thérapeutique des médicaments au Québec.
$0.00 Add to cart -
Potential costs from therapeutic substitution of proton pump inhibitor (PPI) drugs in Quebec.
$0.00 Add to cart -
Adverse drug reactions in Canada: facts v. urban myths.
$0.00 Add to cart -
No link between faster drug approvals, regulatory safety warnings, drug withdrawals in Canada & USA.
$0.00 Add to cart -
Drugs and the public cost of healthcare in Canada.
$0.00 Add to cart -
Complexity and costs of assessing real-world effectiveness of new drugs.
$0.00 Add to cart -
Net societal economic impact in Canada from withholding regulatory approval for generic OxyContin®
Read more